Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wealth Journal.
Press releases published on August 4, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Shareholders who purchased shares of RCKT during the class period listed are encouraged to contact …

Bit Origin Announces Completion of Share Capital Reduction
SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company") today announced that it has completed a reduction of its issued share capital, following the approval by its shareholders and subsequent confirmation …

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in …

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …

Unitil Reports Second Quarter Earnings
HAMPTON, N.H., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) today announced Net Income of $4.0 million, or $0.25 in Earnings Per Share (EPS) for the second quarter of 2025, a decrease of $0.3 million in Net Income, or $0.02 …

LM Funding America Announces Second Quarter 2025 Earnings Call for August 14, 2025
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced that it has scheduled its second quarter 2025 earnings …

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
Cellectis to host an Investor R…

Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités
Cellectis organise un R…

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the …

Vodafone and Kaltura Sign a Long-Term Partnership Agreement to Expand Cloud TV Services
New York, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vodafone Group PLC (Nasdaq: VOD) and Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, today announced that they have extended their partnership around the Kaltura-powered Vodafone TV solution (VTV). …

Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America
MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has expanded its existing relationship and amended its agreement with Incyte …

Thérapeutique Knight et Incyte modifient leur entente d’approvisionnement et de distribution avec l’ajout du retifanlimab et de l’axatilimab en Amérique latine
MONTRÉAL, 04 août 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui l’élargissement de sa relation existante et la modification de son …

Transocean Ltd. Reports Second Quarter 2025 Results
Three months ended Three months ended June 30, 2025 March 31, 2025 sequential change June 30, 2024 year-over-year change (In millions, except per share amounts, percentages and backlog) …

Vornado Announces Second Quarter 2025 Financial Results
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended June 30, 2025 Financial Results NET INCOME attributable to common shareholders for the quarter ended June 30, 2025 was $743,819,000, or $3.70 per …

EXP joins Manatee County to celebrate the completion of the 44th Ave East Extension Project
BRADENTON, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- EXP joined Manatee County officials, the Florida Department of Transportation, SEMA Construction and community members to celebrate the official opening of the 44th Avenue Extension Project. The 44th …

UFP Technologies Announces Record Q2 Results
NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million …

Ryman Hospitality Properties, Inc. Reports Second Quarter 2025 Results
NASHVILLE, Tenn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP), a leading lodging real estate investment trust (“REIT”) specializing in group-oriented, destination hotel assets in urban and resort markets, today reported …

Archrock Reports Second Quarter 2025 Results and Raises 2025 Financial Guidance
HOUSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today reported results for the second quarter 2025. Second Quarter 2025 and Recent Highlights Revenue for the second quarter of 2025 was $383.2 million …

Great Elm Capital Corp. Announces Second Quarter 2025 Financial Results
PALM BEACH GARDENS, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced its financial results for the second quarter ended June 30, 2025. …